AU3471995A - Pharmaceutical formulations comprising clavulanic acid or derivatives and an organic acid or salt - Google Patents
Pharmaceutical formulations comprising clavulanic acid or derivatives and an organic acid or saltInfo
- Publication number
- AU3471995A AU3471995A AU34719/95A AU3471995A AU3471995A AU 3471995 A AU3471995 A AU 3471995A AU 34719/95 A AU34719/95 A AU 34719/95A AU 3471995 A AU3471995 A AU 3471995A AU 3471995 A AU3471995 A AU 3471995A
- Authority
- AU
- Australia
- Prior art keywords
- derivatives
- acid
- salt
- pharmaceutical formulations
- organic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 title 1
- HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 title 1
- 229960003324 clavulanic acid Drugs 0.000 title 1
- 150000007524 organic acids Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9417953A GB9417953D0 (en) | 1994-09-03 | 1994-09-03 | Pharmaceutical formulations |
| GB9417953 | 1994-09-03 | ||
| GB9503752 | 1995-02-24 | ||
| GBGB9503752.9A GB9503752D0 (en) | 1995-02-24 | 1995-02-24 | Pharmaceutical formulations |
| US46044195A | 1995-06-02 | 1995-06-02 | |
| US460441 | 1995-06-02 | ||
| PCT/EP1995/003322 WO1996007408A1 (en) | 1994-09-03 | 1995-08-21 | Pharmaceutical formulations comprising clavulanic acid or derivatives and an organic acid or salt |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3471995A true AU3471995A (en) | 1996-03-27 |
Family
ID=27267365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU34719/95A Abandoned AU3471995A (en) | 1994-09-03 | 1995-08-21 | Pharmaceutical formulations comprising clavulanic acid or derivatives and an organic acid or salt |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0782443A1 (en) |
| JP (1) | JPH10505595A (en) |
| AU (1) | AU3471995A (en) |
| DZ (1) | DZ1926A1 (en) |
| IL (1) | IL115125A0 (en) |
| MA (1) | MA23663A1 (en) |
| TR (1) | TR199501082A2 (en) |
| WO (1) | WO1996007408A1 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ337247A (en) | 1995-09-07 | 2001-05-25 | Smithkline Beecham Corp | Pharmaceutical tablet formulation comprising 875mg amoxycillin |
| ID23673A (en) * | 1997-02-14 | 2000-05-11 | Smithkline Beecham Lab Pharma | PHARMACEUTICAL FORMULATION CONSIST OF AMOXICILIN AND KLAVULANAT |
| US6706290B1 (en) | 1998-07-06 | 2004-03-16 | Olvai E. Kajander | Methods for eradication of nanobacteria |
| JP2002519363A (en) * | 1998-07-06 | 2002-07-02 | カヤンデル，イー・オラヴィ | Eradication of nanobacteria |
| US7250176B1 (en) | 1999-04-13 | 2007-07-31 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection |
| US6294199B1 (en) | 1999-04-13 | 2001-09-25 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising administering amoxycillin |
| US6878386B1 (en) | 1999-04-13 | 2005-04-12 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate |
| WO2002030392A2 (en) | 2000-10-12 | 2002-04-18 | Beecham Pharmaceuticals (Pte) Limited | Formulation containing amoxicillin |
| US6756057B2 (en) | 2000-10-12 | 2004-06-29 | Beecham Pharmaceuticals (Pte) Limited | Amoxicillin and potassium clavulanate dosage form |
| US8614315B2 (en) * | 2009-12-25 | 2013-12-24 | Mahmut Bilgic | Cefdinir and cefixime formulations and uses thereof |
| TR201000688A2 (en) | 2010-01-29 | 2011-08-22 | B�Lg�� Mahmut | Effervescent formulations containing cefaclor and clavulanic acid as active ingredient. |
| WO2011152806A1 (en) * | 2010-06-03 | 2011-12-08 | Mahmut Bilgic | Production method for the effervescent formulation comprising cephalosporin and potassium clavulanate |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0002312B1 (en) * | 1977-11-26 | 1982-02-03 | Beecham Group Plc | Derivatives of clavulanic acid and pharmaceutical compositions containing them |
| NZ198241A (en) * | 1980-09-27 | 1983-12-16 | Beecham Group Ltd | Tablet containing amoxycillin and potassium clavulanate |
| JPH08505868A (en) * | 1993-01-22 | 1996-06-25 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | Pharmaceutical formulations consisting of clavulanic acid alone or clavulanic acid mixed with other beta-lactam antibiotics |
-
1995
- 1995-08-02 DZ DZ950107A patent/DZ1926A1/en active
- 1995-08-21 JP JP8509160A patent/JPH10505595A/en not_active Ceased
- 1995-08-21 EP EP95931176A patent/EP0782443A1/en not_active Withdrawn
- 1995-08-21 AU AU34719/95A patent/AU3471995A/en not_active Abandoned
- 1995-08-21 WO PCT/EP1995/003322 patent/WO1996007408A1/en not_active Ceased
- 1995-08-31 TR TR95/01082A patent/TR199501082A2/en unknown
- 1995-09-01 MA MA24005A patent/MA23663A1/en unknown
- 1995-09-01 IL IL11512595A patent/IL115125A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA23663A1 (en) | 1996-04-01 |
| JPH10505595A (en) | 1998-06-02 |
| WO1996007408A1 (en) | 1996-03-14 |
| IL115125A0 (en) | 1995-12-31 |
| TR199501082A2 (en) | 1996-06-21 |
| DZ1926A1 (en) | 2002-02-17 |
| EP0782443A1 (en) | 1997-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2505795A (en) | 1-arylpyrimidine derivatives and pharmaceutical use thereof | |
| IL128600A0 (en) | Propionic acid derivatives and pharmaceutical compositions containing them | |
| IL131201A (en) | Pharmaceutical formulations comprising amoxycillin and clavulanate | |
| AU6995396A (en) | Pharmaceutical formulation | |
| HUP9901437A3 (en) | Pharmaceutical formulation, containing amoxycillin and clavulanate | |
| AU2415299A (en) | Substituted benzenesulfonamide derivatives and their pharmaceutical use | |
| AU5814096A (en) | Composition comprising amoxycillin and clavulanic acid | |
| AU5856898A (en) | Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them | |
| PL345564A1 (en) | Pharmaceutical suspension formulation comprising amoxycillin, clavulanic acid and cellulose | |
| AU3471995A (en) | Pharmaceutical formulations comprising clavulanic acid or derivatives and an organic acid or salt | |
| AU5647199A (en) | Carboxylic acid derivatives and drugs containing the same as the active ingredient | |
| AU5443499A (en) | Carboxylic acid derivatives and drugs containing the same as the active ingredient | |
| AU7582696A (en) | Pharmaceutical formulation | |
| AU7275894A (en) | Imidazolylalkylamine derivative and pharmaceutical composition thereof | |
| AU4123396A (en) | Cephem compounds and pharmaceutical use thereof | |
| AU7449198A (en) | Phthalimide derivatives and pharmaceutical containing said derivatives | |
| AU3407597A (en) | Useful formulations of acid addition salt drugs | |
| AU6120298A (en) | 2-peperazinone-1-acetic acid derivatives and their use | |
| AU3363193A (en) | Pharmaceutical formulations comprising a clavulanic acid salt and erithromycin derivative | |
| AU2792695A (en) | Amino acid derivatives and their use as pesticides | |
| AU6944696A (en) | Novel phenylacetic acid derivatives and medicinal composition containing the same | |
| AU6690394A (en) | Imidazolylquinoxalinedione derivative and pharmaceutical composition thereof | |
| AU7551896A (en) | 1-azabicycloheptane derivatives and their pharmaceutical use | |
| AU3107497A (en) | Asialotrisaccharide moranoline derivatives and drugs | |
| HK1003151A (en) | Pharmaceutical formulations comprising clavulanic acid or derivatives and an organic acid or salt |